Literature DB >> 908471

Serum free insulin concentrations during the treatment of diabetic coma and precoma with low dose intramuscular insulin.

C M Asplin, M Hartog.   

Abstract

Fifty patients in diabetic coma or precoma, 33 of whom had previously received insulin and had circulating insulin antibodies, were studied during treatment with a low-dose intramuscular insulin regime. In the presence of insulin antibodies, serum free insulin was separated from bound insulin by steady-state gel filtration. The initial mean serum free insulin concentration in the group of patients without insulin antibodies was 9 mU/1, 1 to 2 hours after intramuscular therapy it had risen to 22 mU/1, and after 7 to 8 hours to 73 mU/1. The corresponding concentrations for the group with insulin antibodies were 13, 23 and 74 mU/1. No relationship was found between the concentrations of serum free insulin attained and the age of the patients, their initial degree of acidosis, dehydration, and systolic blood pressure, the insulin antibody characteristics of their sera, nor the rate of decline of the blood glucose.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 908471     DOI: 10.1007/bf01234499

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  18 in total

1.  Quantitative aspects of the reaction between insulin and insulin-binding antibody.

Authors:  S A BERSON; R S YALOW
Journal:  J Clin Invest       Date:  1959-11       Impact factor: 14.808

2.  Treatment of diabetic coma with small intravenous insulin boluses.

Authors:  N Clumeck; A De Troyer; R Naeije; G Somers; L Smekens; E O Balasse
Journal:  Br Med J       Date:  1976-08-14

3.  A simple method for the determination of serum free insulin levels in insulin-treated patients.

Authors:  S Nakagawa; H Nakayama; T Sasaki; K Yoshino; Y Y Yu
Journal:  Diabetes       Date:  1973-08       Impact factor: 9.461

4.  Growth-hormone and cortisol responses to insulin infusion in patients with diabetes mellitus.

Authors:  P H Sönksen; M C Srivastava; C V Tompkins; J D Nabarro
Journal:  Lancet       Date:  1972-07-22       Impact factor: 79.321

5.  Determination of free and antibody-bound insulin in insulin treated diabetic patients.

Authors:  L G Heding
Journal:  Horm Metab Res       Date:  1969-05       Impact factor: 2.936

6.  Accurate measurement of steroid-protein binding by steady-state gel filtration.

Authors:  C W Burke
Journal:  Biochim Biophys Acta       Date:  1969-03-04

7.  Determination of blood glucose using an oxidase-peroxidase system with a non-carcinogenic chromogen.

Authors:  P Trinder
Journal:  J Clin Pathol       Date:  1969-03       Impact factor: 3.411

8.  The binding of cholic acid and its taurine conjugate to serum proteins.

Authors:  C W Burke; B Lewis; D Panveliwalla; S Tabaqchali
Journal:  Clin Chim Acta       Date:  1971-04       Impact factor: 3.786

9.  Diabetic crises in children treated with small doses of intramuscular insulin.

Authors:  J Moseley
Journal:  Br Med J       Date:  1975-01-11

10.  Treatment of diabetic coma with continuous low-dose infusion of insulin.

Authors:  M M Page; K G Alberti; R Greenwood; K A Gumaa; T D Hockaday; C Lowy; J D Nabarro; D A Pyke; P H Sönksen; P J Watkins; T E West
Journal:  Br Med J       Date:  1974-06-29
View more
  3 in total

1.  Severe ketoacidosis as the first manifestation of diabetes mellitus after age fifty.

Authors:  S A Peter
Journal:  J Natl Med Assoc       Date:  1986-02       Impact factor: 1.798

2.  Treatment of severe diabetic ketoacidosis. A comparative study of two methods.

Authors:  J A Lutterman; A A Adriaansen; A van 't Laar
Journal:  Diabetologia       Date:  1979-07       Impact factor: 10.122

Review 3.  Adverse effects of exogenous insulin. Clinical features, management and prevention.

Authors:  A W Patrick; G Williams
Journal:  Drug Saf       Date:  1993-06       Impact factor: 5.606

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.